Description
MODIFICATION FOR OY 3 - RADIOPHARMACEUTICALS 4/1/2020 - 3/31/2021
Base award description: RADIOPHARMACEUTICALS
Modification chain · 7 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-04-01+$0= $0
- Mod P000012017-01-23+$0= $0
- Mod P000022018-03-30+$0= $0
- Mod P000032019-04-01+$0= $0
- Mod P000042020-03-30+$0= $0
- Mod P000052020-10-13+$0= $0
- Mod P000062022-02-15+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-04-01 | +$0 | $0 | RADIOPHARMACEUTICALS |
| Mod P00001· EXERCISE AN OPTION | 2017-01-23 | +$0 | $0 | MODIFICATION FOR OY1 - RADIOPHARMACEUTICALS 4/1/2017 - 3/31/2018 |
| Mod P00002· EXERCISE AN OPTION | 2018-03-30 | +$0 | $0 | MODIFICATION FOR OY 2 - RADIOPHARMACEUTICALS 4/1/2018 - 3/31/2019 |
| Mod P00003· EXERCISE AN OPTION | 2019-04-01 | +$0 | $0 | MODIFICATION FOR OY 3 - RADIOPHARMACEUTICALS 4/1/2019 - 3/31/2020 |
| Mod P00004· OTHER ADMINISTRATIVE ACTION | 2020-03-30 | +$0 | $0 | MODIFICATION FOR OY 3 - RADIOPHARMACEUTICALS 4/1/2020 - 3/31/2021 |
| Mod P00005· NOVATION AGREEMENT | 2020-10-13 | +$0 | $0 | MODIFICATION FOR OY 3 - RADIOPHARMACEUTICALS 4/1/2020 - 3/31/2021 |
| Mod P00006· OTHER ADMINISTRATIVE ACTION | 2022-02-15 | +$0 | $0 | MODIFICATION FOR OY 3 - RADIOPHARMACEUTICALS 4/1/2020 - 3/31/2021 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CPZEFNJH8MF3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0438 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $1,160,000 | FY2026 |
| 36C25525N0325 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $970,000 | FY2025 |
| 36C25524N0322 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $440,058 | FY2024 |
| 36C25523N0460 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $280,461 | FY2023 |
| 36C25522N0466 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $247,662 | FY2022 |
| 36C25522D0063 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2022 |
Other recipients under 6505 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25526F0111 | LANTHEUS MEDICAL IMAGING, INC. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $541,308 | FY2026 |
| 36C25526N0397 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $77,695 | FY2026 |
| 36C25526N0376 | RED RIVER PHARMACY OF JONESBORO, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $233,435 | FY2026 |
| 36C25526N0394 | NOVARTIS PHARMACEUTICALS CORPORATION | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $891,651 | FY2026 |
| 36C25526N0392 | SOFIE CO. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $357,066 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA25516D0096_3600 · retrieved 2026-09-27.